nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—Neoplasm—Teniposide—lymphatic system cancer	0.0377	0.0377	CcSEcCtD
Desogestrel—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0269	0.0269	CcSEcCtD
Desogestrel—Alopecia—Mechlorethamine—lymphatic system cancer	0.0251	0.0251	CcSEcCtD
Desogestrel—Neoplasm—Carmustine—lymphatic system cancer	0.0212	0.0212	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0209	0.0209	CcSEcCtD
Desogestrel—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0196	0.0196	CcSEcCtD
Desogestrel—Alopecia—Teniposide—lymphatic system cancer	0.0185	0.0185	CcSEcCtD
Desogestrel—Vaginal discharge—Methotrexate—lymphatic system cancer	0.0179	0.0179	CcSEcCtD
Desogestrel—Erythema multiforme—Fludarabine—lymphatic system cancer	0.0174	0.0174	CcSEcCtD
Desogestrel—Alopecia—Fludarabine—lymphatic system cancer	0.0163	0.0163	CcSEcCtD
Desogestrel—Malnutrition—Fludarabine—lymphatic system cancer	0.016	0.016	CcSEcCtD
Desogestrel—Hypertension—Teniposide—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Desogestrel—Weight decreased—Bleomycin—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Desogestrel—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Desogestrel—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Desogestrel—Vomiting—Mechlorethamine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Desogestrel—Nervous system disorder—Fludarabine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Desogestrel—Rash—Mechlorethamine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Desogestrel—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Desogestrel—Weight decreased—Vincristine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Desogestrel—Weight increased—Mitoxantrone—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Desogestrel—Weight decreased—Mitoxantrone—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Desogestrel—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Desogestrel—Nausea—Mechlorethamine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Desogestrel—Alopecia—Bleomycin—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Desogestrel—Urticaria—Teniposide—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Desogestrel—Abdominal pain—Teniposide—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Desogestrel—Eye disorder—Carmustine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Desogestrel—Hypersensitivity—Teniposide—lymphatic system cancer	0.011	0.011	CcSEcCtD
Desogestrel—Alopecia—Carmustine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Desogestrel—Mental disorder—Carmustine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Desogestrel—Malnutrition—Carmustine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Desogestrel—Diarrhoea—Teniposide—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Desogestrel—Alopecia—Vincristine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Desogestrel—Mental disorder—Vincristine—lymphatic system cancer	0.00986	0.00986	CcSEcCtD
Desogestrel—Neoplasm—Methotrexate—lymphatic system cancer	0.00983	0.00983	CcSEcCtD
Desogestrel—Alopecia—Mitoxantrone—lymphatic system cancer	0.00969	0.00969	CcSEcCtD
Desogestrel—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00964	0.00964	CcSEcCtD
Desogestrel—Vomiting—Teniposide—lymphatic system cancer	0.00947	0.00947	CcSEcCtD
Desogestrel—Rash—Teniposide—lymphatic system cancer	0.00939	0.00939	CcSEcCtD
Desogestrel—Dermatitis—Teniposide—lymphatic system cancer	0.00938	0.00938	CcSEcCtD
Desogestrel—Headache—Teniposide—lymphatic system cancer	0.00933	0.00933	CcSEcCtD
Desogestrel—Diarrhoea—Fludarabine—lymphatic system cancer	0.00896	0.00896	CcSEcCtD
Desogestrel—Hypertension—Carmustine—lymphatic system cancer	0.00886	0.00886	CcSEcCtD
Desogestrel—Nausea—Teniposide—lymphatic system cancer	0.00885	0.00885	CcSEcCtD
Desogestrel—Hypertension—Vincristine—lymphatic system cancer	0.00846	0.00846	CcSEcCtD
Desogestrel—Vomiting—Fludarabine—lymphatic system cancer	0.00832	0.00832	CcSEcCtD
Desogestrel—Rash—Fludarabine—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Desogestrel—Dermatitis—Fludarabine—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Desogestrel—Hypertension—Mitoxantrone—lymphatic system cancer	0.00824	0.00824	CcSEcCtD
Desogestrel—Headache—Fludarabine—lymphatic system cancer	0.0082	0.0082	CcSEcCtD
Desogestrel—Nervous system disorder—Vincristine—lymphatic system cancer	0.00784	0.00784	CcSEcCtD
Desogestrel—Nausea—Fludarabine—lymphatic system cancer	0.00778	0.00778	CcSEcCtD
Desogestrel—Urticaria—Bleomycin—lymphatic system cancer	0.00763	0.00763	CcSEcCtD
Desogestrel—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00757	0.00757	CcSEcCtD
Desogestrel—Mood swings—Methotrexate—lymphatic system cancer	0.00748	0.00748	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00723	0.00723	CcSEcCtD
Desogestrel—Breast disorder—Methotrexate—lymphatic system cancer	0.00714	0.00714	CcSEcCtD
Desogestrel—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00707	0.00707	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Desogestrel—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00685	0.00685	CcSEcCtD
Desogestrel—Abdominal pain—Carmustine—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Desogestrel—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Desogestrel—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00637	0.00637	CcSEcCtD
Desogestrel—Abdominal pain—Vincristine—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Desogestrel—Urticaria—Mitoxantrone—lymphatic system cancer	0.00619	0.00619	CcSEcCtD
Desogestrel—Hypersensitivity—Carmustine—lymphatic system cancer	0.00617	0.00617	CcSEcCtD
Desogestrel—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Desogestrel—Vomiting—Bleomycin—lymphatic system cancer	0.0061	0.0061	CcSEcCtD
Desogestrel—Rash—Bleomycin—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Desogestrel—Dermatitis—Bleomycin—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Desogestrel—Hypersensitivity—Vincristine—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Desogestrel—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Desogestrel—Diarrhoea—Carmustine—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Desogestrel—Nausea—Bleomycin—lymphatic system cancer	0.0057	0.0057	CcSEcCtD
Desogestrel—Diarrhoea—Vincristine—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Desogestrel—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Desogestrel—Vomiting—Carmustine—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Desogestrel—Rash—Carmustine—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Desogestrel—Dermatitis—Carmustine—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Desogestrel—Headache—Carmustine—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Desogestrel—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Desogestrel—Eye disorder—Methotrexate—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Desogestrel—Vomiting—Vincristine—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Desogestrel—Rash—Vincristine—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Desogestrel—Dermatitis—Vincristine—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Desogestrel—Headache—Vincristine—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Desogestrel—Nausea—Carmustine—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Desogestrel—Vomiting—Mitoxantrone—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Desogestrel—Immune system disorder—Methotrexate—lymphatic system cancer	0.00493	0.00493	CcSEcCtD
Desogestrel—Rash—Mitoxantrone—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Desogestrel—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Desogestrel—Headache—Mitoxantrone—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Desogestrel—Alopecia—Methotrexate—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Desogestrel—Mental disorder—Methotrexate—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Desogestrel—Malnutrition—Methotrexate—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Desogestrel—Nausea—Vincristine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Desogestrel—Nausea—Mitoxantrone—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Desogestrel—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Desogestrel—Skin disorder—Methotrexate—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Desogestrel—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Desogestrel—Urticaria—Methotrexate—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Desogestrel—Abdominal pain—Methotrexate—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Desogestrel—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Desogestrel—Diarrhoea—Methotrexate—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Desogestrel—Vomiting—Methotrexate—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Desogestrel—Rash—Methotrexate—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Desogestrel—Dermatitis—Methotrexate—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Desogestrel—Headache—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Desogestrel—Nausea—Methotrexate—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
